Chao‐Hung Wang

7.5k total citations · 3 hit papers
153 papers, 5.8k citations indexed

About

Chao‐Hung Wang is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Chao‐Hung Wang has authored 153 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Cardiology and Cardiovascular Medicine, 35 papers in Molecular Biology and 26 papers in Surgery. Recurrent topics in Chao‐Hung Wang's work include Heart Failure Treatment and Management (27 papers), Cardiovascular Function and Risk Factors (27 papers) and Cardiac Imaging and Diagnostics (21 papers). Chao‐Hung Wang is often cited by papers focused on Heart Failure Treatment and Management (27 papers), Cardiovascular Function and Risk Factors (27 papers) and Cardiac Imaging and Diagnostics (21 papers). Chao‐Hung Wang collaborates with scholars based in Taiwan, Canada and United States. Chao‐Hung Wang's co-authors include Subodh Verma, Richard D. Weisel, Paul W.M. Fedak, Ren‐Ke Li, Donald A.G. Mickle, Paul E. Szmitko, Wen‐Jin Cherng, Shuhong Li, Min‐Hui Liu and Aaron S. Dumont and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Chao‐Hung Wang

146 papers receiving 5.7k citations

Hit Papers

A Self-Fulfilling Prophecy 2002 2026 2010 2018 2002 2003 2003 250 500 750

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Chao‐Hung Wang 2.1k 1.6k 1.4k 1.0k 911 153 5.8k
Po‐Hsun Huang 1.6k 0.8× 753 0.5× 2.1k 1.5× 1.2k 1.1× 867 1.0× 248 6.5k
Paolo Calabrò 3.6k 1.7× 1.5k 0.9× 1.3k 0.9× 1.6k 1.6× 788 0.9× 298 7.4k
Felix C. Tanner 3.6k 1.7× 1.1k 0.7× 2.0k 1.5× 2.1k 2.1× 1.2k 1.4× 222 8.2k
Aldo Clerico 4.3k 2.0× 938 0.6× 1.0k 0.8× 979 1.0× 507 0.6× 261 6.9k
Milton Packer 3.5k 1.6× 3.6k 2.2× 2.3k 1.7× 841 0.8× 792 0.9× 94 8.8k
Masatsugu Hori 3.6k 1.7× 1.0k 0.6× 2.0k 1.5× 1.7k 1.7× 678 0.7× 197 8.2k
Luís Eduardo Paim Rohde 4.1k 1.9× 835 0.5× 977 0.7× 1.3k 1.3× 414 0.5× 180 6.6k
Markus van der Giet 2.4k 1.1× 708 0.4× 2.3k 1.7× 1.8k 1.8× 1.0k 1.1× 253 9.6k
Isao Kubota 3.7k 1.7× 858 0.5× 1.8k 1.3× 943 0.9× 994 1.1× 384 7.7k
Kenneth McDonald 5.0k 2.4× 737 0.5× 1.2k 0.9× 1.1k 1.1× 401 0.4× 222 7.8k

Countries citing papers authored by Chao‐Hung Wang

Since Specialization
Citations

This map shows the geographic impact of Chao‐Hung Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chao‐Hung Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chao‐Hung Wang more than expected).

Fields of papers citing papers by Chao‐Hung Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chao‐Hung Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chao‐Hung Wang. The network helps show where Chao‐Hung Wang may publish in the future.

Co-authorship network of co-authors of Chao‐Hung Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Chao‐Hung Wang. A scholar is included among the top collaborators of Chao‐Hung Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chao‐Hung Wang. Chao‐Hung Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Liu, Min‐Hui, et al.. (2024). Extensive Dysregulation of Phenylalanine Metabolism Is Associated With Stress Hyperphenylalaninemia and 30‐Day Death in Critically Ill Patients With Acute Decompensated Heart Failure. Journal of the American Heart Association. 13(18). e035821–e035821. 1 indexed citations
3.
Verma, Subodh, Adrian Quan, Chao‐Hung Wang, et al.. (2023). Empagliflozin improves circulating vascular regenerative cell content in people without diabetes with risk factors for adverse cardiac remodeling. American Journal of Physiology-Heart and Circulatory Physiology. 325(5). H1210–H1222. 8 indexed citations
4.
Taniar, David, et al.. (2023). Progression to myocardial infarction short-term death based on interval sequential pattern mining. BMC Cardiovascular Disorders. 23(1). 394–394. 3 indexed citations
5.
Hsu, Heng-Jung, I‐Wen Wu, Min‐Hui Liu, et al.. (2021). The association between low protein diet and body composition, muscle function, inflammation, and amino acid-based metabolic profile in chronic kidney disease stage 3–5 patients. Clinical Nutrition ESPEN. 46. 405–415. 18 indexed citations
6.
Tang, Hsiang-Yu, Chao‐Hung Wang, Hung‐Yao Ho, et al.. (2020). Characteristic of Metabolic Status in Heart Failure and Its Impact in Outcome Perspective. Metabolites. 10(11). 437–437. 20 indexed citations
7.
Wang, Chao‐Hung, Chi‐Wen Cheng, Min‐Hui Liu, et al.. (2020). Elevated Plasma Phenylalanine Predicts Mortality in Critical Patients with Heart Failure. ESC Heart Failure. 7(5). 2884–2893. 40 indexed citations
8.
Liu, Minghui, et al.. (2019). Phenylalanine- and leucine-defined metabolic types identify high mortality risk in patients with severe infection. International Journal of Infectious Diseases. 85. 143–149. 44 indexed citations
9.
Liu, Yu‐Chih, et al.. (2019). <p>Amino Acid-Based Metabolic Indexes Identify Patients With Chronic Obstructive Pulmonary Disease And Further Discriminates Patients In Advanced BODE Stages</p>. International Journal of COPD. Volume 14. 2257–2266. 16 indexed citations
10.
Cheng, Chi‐Wen, et al.. (2018). Predictors of long-term survival prior to permanent pacemaker implantation in octogenarians or older. Aging Clinical and Experimental Research. 31(7). 1001–1009. 7 indexed citations
11.
Wang, Chao‐Hung, Yen-Yi Wu, Jianli Chen, et al.. (2017). An effective legalization algorithm for mixed-cell-height standard cells. 450–455. 39 indexed citations
12.
Wang, Chao‐Hung, Mei‐Ling Cheng, Min‐Hui Liu, Li‐Tang Kuo, & Ming‐Shi Shiao. (2017). Metabolic profile provides prognostic value better than galectin-3 in patients with heart failure. Journal of Cardiology. 70(1). 92–98. 15 indexed citations
13.
Chien, Ming-Nan, et al.. (2015). Basal Insulin Initiation in Elderly Patients with Type 2 Diabetes in Taiwan: A Comparison with Younger Patients. International journal of gerontology. 9(3). 142–145. 2 indexed citations
14.
Cheng, Mei‐Ling, Chao‐Hung Wang, Ming‐Shi Shiao, et al.. (2015). Metabolic Disturbances Identified in Plasma Are Associated With Outcomes in Patients With Heart Failure. Journal of the American College of Cardiology. 65(15). 1509–1520. 241 indexed citations
15.
Liu, Min‐Hui, Chao‐Hung Wang, Chi‐Ming Lee, Yu-Yen Huang, & Wen‐Jin Cherng. (2011). Disease knowledge, self-care behaviours and life quality in heart failure: Experience of the Taiwan National Health care. 7(5). 269–279. 1 indexed citations
16.
Chien, Ming-Nan, et al.. (2011). Effect of Sitagliptin as Add-on Therapy in Elderly Type 2 Diabetes Patients With Inadequate Glycemic Control in Taiwan. SHILAP Revista de lepidopterología. 5(2). 103–106. 17 indexed citations
17.
Hsu, Li‐Chang & Chao‐Hung Wang. (2008). A Study of E-Trust in Online Auctions. Journal of electronic commerce research. 9(4). 310. 22 indexed citations
18.
Liu, Min‐Hui, et al.. (2008). Sea Mango Cardiac Intoxication. Zhōnghuá mínguó xīnzàngxué huì zázhì. 24(1). 56–59. 5 indexed citations
19.
Wang, Chao‐Hung, et al.. (2006). Safety and Effectiveness of Rosiglitazone in Type 2 Diabetes Patients with Nonalcoholic Fatty Liver Disease. Journal of the Formosan Medical Association. 105(9). 743–752. 32 indexed citations
20.
Wang, Chao‐Hung, Shuhong Li, Richard D. Weisel, et al.. (2004). 867-5 Rosiglitazone modulates angiogenic progenitor cell differentiation and attenuates intimal hyperplasia after vascular intervention. Journal of the American College of Cardiology. 43(5). A527–A527.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026